ArticleJournal of thrombosis and thrombolysis2022

Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.

Mark L Vestal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.